prof. dr. E.A.M. (Elisabeth ) Sanders
prof. dr. E.A.M. (Elisabeth ) Sanders
- Cluster B
Dr. Prof. Elisabeth AM Sanders (F), born in 1959 is paediatrician and Professor in Pediatric Immunology and Infectious Diseases at the University Medical Center Utrecht in combination with a position as Chief Science Officer (Immunology, Infectiology and Vaccinology) at the Netherlands National Institute for Public Health and Environment (RIVM). She has a H-index of 38 and wrote over 250 peer reviewed manuscripts in international journals . She was head of the clinical department of Immunology and Infectious Diseases of the University Children’s Hospital Utrecht between 2004-2009. Between 2009 -2014 she was director Research and Education of the University Hospital for Children in Utrecht. She has a long standing interest in the clinical effectiveness of vaccines, prevention of respiratory infections and development of microbiome and immunity in children. At present, her research focus is optimizing current national vaccination programmes for children and elderly, epidemiology and prevention of respiratory tract infections and respiratory microbiome profile development in health and disease.
Since 2010, she is a member of the Health Council for the Ministry of Health. She has participated in many scientific advisory boards for the national Health Council.
(INTER) NATIONAL COMMITTEES AND BOARDS
2021- Consultant (geraadpleegd deskundige) National Health Council on COVID-19 vaccination strategies (gezondheidsraad COVID-19 vaccinatie)
2021- (co-)Director wetenschappelijk inhoudelijk COVID-19 vaccinatie programma RIVM (naast Hans van Vliet)
2020- Consultant Outbreak Management Team on SARS-CoV-2/COVID-19
2019 - Co-initiator of IGJ AIOS Conference (since 2017, twice a year) with the aim of improved interaction between Inspection (IGJ) and doctors in training
2019 - Member NWO selection Committee VIDI candidates
2019- Member of Conference Committee National Society for Paediatrics in the Netherlands, NVK
2017- Member of the International Coalition for Life Course Immunization (CLCI)
2016- WHO: Member of WHO SAGE working group on pneumococcal vaccines
2016 - 2018 Member of Faculty Masterclasses Vaccinology
2016 - Observer at the JCVI meetings (3-4 times per year), UK
2010 - 2018 Member of the Health Council
2011 - 2015 National Pediatric Society (NVK); board member scientific committee
2007 - 2015 Member Health Council of the Netherlands; Member of the council group (Beraadgroep) on Infections and Immunity
2013 - 2014 Health Council of the Netherlands; member of the council committee on the national program for FLU vaccination.
2013 - 2014 Health Council of the Netherlands; member of the council committee on the national immunization program (Commission RVP) of the National Health Council.
2005 - 2014 Stichting Afweerstoornissen, SAS, Chair scientific advice committee Patient Society for Immunodeficiency disease.
2001 - 2013 Board member responsible for the Organization of the scientific meetings of the Interuniversity working party for the Study of Immune deficiencies
2013 Member NWO VENI selection committee
2013 Member scientific board ISPPD conference India, March 2014
2007 - 2012 KNAW- Royal Netherlands Academy of Arts and Sciences, Chair of the Scientific Advisory Board of the TerMeulenFonds” –
2012 World Health Organization meeting PneumoCarr March 27-28th in Geneva, March 27/28.
2003 - 2012 Dutch Society of Pediatrics, NVK, member of the selection committee for the Young Investigators Award
2011 Health Council of the Netherlands, member of the council committee on population screening for cervical cancer.
2011 Member scientific committee ESPID conference June 2011
2010 National Health Council Advisory member of the committee on vaccination of newborns against pneumococcal infections
2003 - 2009 Member of the Board of Trustees of the National Vaccine Institute, NVI
2009 National Health Council Advisory member of the committee on vaccination against pandemic Flu.
2004 - 2008 KNAW- Royal Netherlands Academy of Arts and Sciences. Member of the scientific Advisory Board of the TerMeulen Fonds –
1997 - 2007 Board member/Treasurer of the Pediatric Immunology Section of the Dutch Society of Pediatrics
2002 Committee for the Ministry of Health, for the National Vaccination Program regarding pneumococcal and Meningococcal C vaccinations, advisory member.
2001 Member Cochrane Collaboration on Pneumococcal Vaccines and Otitis Media
Potential Conflicts of Interest
Besides her function as Professor at the University of Utrecht and position (0.2 Fte) at the Wilhelmina Children’s Hospital, Lieke Sanders has a full-time position at the National Institute of Public Health and the Environment (RIVM) as Chief Science Officer since December 2014. Since January 2021 she is co-medical director of the COVID-19 vaccination programme at RIVM. She is member of the WHO-SAGE committee on pneumococcal vaccinations, consultant for the national Health Council committee for COVID-19 vaccination (incidenteel geraadpleegd deskundige) without any personal fee or benefit.
Dr Sanders has no research connections with pharmaceutical or industrial partners since 2014, besides as research partner in IMI-funded studies RESCEU and PROMISE projects with partners GSK, Novavax, Janssen, AstraZeneca, Pfizer and Sanofi. She receives no personal fees or other personal benefits from any collaboration as RIVM partner in these studies or research.
No other conflict of interest to report.
Fellowship and Awards
Research Output (500)
Reyman Marta, van Houten Marlies A., Watson Rebecca L., Chu Mei Ling J.N., Arp Kayleigh, de Waal Wouter J., Schiering Irene, Plötz Frans B., Willems Rob J.L., van Schaik Willem, Sanders Elisabeth A.M., Bogaert Debby 16 Feb 2022, In: Nature Communications. 13
de Koff Emma M., van Houten Marlies A., de Heij Femke, Berbers Guy A.M., Bogaert Debby, Sanders Elisabeth A.M. 24 Jan 2022, In: Vaccine. 40 , p. 408-413 6 p.
Hullegie Saskia, Venekamp Roderick P, van Dongen Thijs M A, Mulder Sanne, van Schaik Willem, de Wit G Ardine, Hay Alastair D, Little Paul, Moore Michael V, Sanders Elisabeth A M, Bonten Marc J M, Bogaert Debby, Schilder Anne Gm, Damoiseaux Roger A M J 16 Dec 2021, In: BMJ Open. 11
Immink Maarten M., Bekker Mireille N., de Melker Hester E., Rots Nynke Y., Sanders Elisabeth A.M., van der Maas Nicoline A.T. Dec 2021, In: BMC Infectious Diseases. 21 , p. 1-9
Miellet Willem R., Mariman Rob, Pluister Gerlinde, de Jong Lieke J., Grift Ivo, Wijkstra Stijn, van Logchem Elske M., van Veldhuizen Janieke, Immink Marie Monique, Wijmenga-Monsuur Alienke J., Rots Nynke Y., Sanders Elisabeth A.M., Bosch Thijs, Trzciński Krzysztof 30 Nov 2021, In: Scientific Reports. 11 , p. 1-9
Jean Baptiste Anne Eudes, Masresha Balcha, Wagai John, Luce Richard, Oteri Joseph, Dieng Boubacar, Bawa Samuel, Ikeonu Obianuju Caroline, Chukwuji Martin, Braka Fiona, Sanders E. A.M., Hahné Susan, Hak Eelko 17 Nov 2021, In: Vaccine. 39 , p. C89-C95
Miellet Willem R., Van Veldhuizen Janieke, Nicolaie Mioara A., Mariman Rob, Bootsma Hester J., Bosch Thijs, Rots Nynke Y., Sanders Elisabeth A.M., Van Beek Josine, Trzciński Krzysztof 1 Nov 2021, In: Clinical Infectious Diseases. 73 , p. E2680-E2689
Versteegen Pauline, Berbers Guy A.M., Smits Gaby, Sanders Elisabeth A.M., van der Klis Fiona R.M., de Melker Hester E., van der Maas Nicoline A.T. Nov 2021, In: The Lancet Regional Health - Europe. 10 , p. 1-9
Koenen Mischa, Bosma Marleen, Roorda Udo, Wopereis Fabienne, Roos Anja, van der Vries Erhard, Bogaert D, Sanders Elisabeth , Boes Marianne, Heidema Jojanneke, van Montfrans JM, Balemans Walter A F, van Holten Thijs C, Verhagen Lilly 29 Oct 2021, In: Clinical and Translational Immunology. 10 10 p.
Reyman Marta, Clerc Melanie, van Houten Marlies A., Arp Kayleigh, Chu Mei Ling J.N., Hasrat Raiza, Sanders Elisabeth A.M., Bogaert Debby 28 Oct 2021, In: Communications biology. 4